RBC Capital analyst Geoffrey Kwan maintains Chesswood Group (TSX:CHW) with a Sector Perform and lowers the price target from C$13 to C$12.
Gamida Cell Ltd. Announces Data Published In Transplantation And Cellular Therapy Suggest Antiviral Protection After Transplantation With Co’s Omisirge
Faster immune reconstitution and decreased rate of post-transplant viral infection in patients transplanted with Omisirge versus umbilical cord blood
Gamida Cell Ltd. (NASDAQ:GMDA), a cell therapy pioneer working